SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1

[1]  Victor G. Puelles,et al.  Molecular consequences of SARS-CoV-2 liver tropism , 2022, Nature Metabolism.

[2]  Evan T. Sholle,et al.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 , 2021, Cell Metabolism.

[3]  Daniel M. Lidar,et al.  Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort , 2021, Science Translational Medicine.

[4]  Pranav Mehta,et al.  COVID-19–Induced New-Onset Diabetes: Trends and Technologies , 2021, Diabetes.

[5]  I. Shimomura,et al.  Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19 , 2021, Diabetes.

[6]  M. Utlu,et al.  The relationship of serum testosterone levels with the clinical course and prognosis of COVID‐19 disease in male patients: A prospective study , 2021, Andrology.

[7]  J. Kolls,et al.  SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes , 2021, JCI insight.

[8]  A. Proietti,et al.  COVID-19 autopsy cases: detection of virus in endocrine tissues , 2021, Journal of Endocrinological Investigation.

[9]  J. Bonventre,et al.  Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection , 2021, Nature Metabolism.

[10]  G. Nolan,et al.  SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment , 2021, Cell Metabolism.

[11]  Xiaolei Tang,et al.  The Effects of Insulin-Like Growth Factor I and BTP-2 on Acute Lung Injury , 2021, International journal of molecular sciences.

[12]  A. Cavalli,et al.  How Genetics Might Explain the Unusual Link Between Malaria and COVID-19 , 2021, Frontiers in Medicine.

[13]  M. Weirauch,et al.  IRF1 governs the differential interferon-stimulated gene responses in human monocytes and macrophages by regulating chromatin accessibility , 2021, Cell reports.

[14]  David A. Knowles,et al.  An integrated approach to identify environmental modulators of genetic risk factors for complex traits , 2021, bioRxiv.

[15]  V. Arumugaswami,et al.  Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells , 2021, Frontiers in Cellular and Infection Microbiology.

[16]  A. Stenzinger,et al.  SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas , 2021, Nature Metabolism.

[17]  D. Accili.  Can COVID-19 cause diabetes? , 2021, Nature Metabolism.

[18]  M. Eisenberg,et al.  Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection , 2021, Therapeutic advances in endocrinology and metabolism.

[19]  J. Bloom,et al.  Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2–induced systemic toxicity , 2020, JCI Insight.

[20]  Linda T. Nieman,et al.  Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection , 2020, Nature Communications.

[21]  Hongyu Zhao,et al.  Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men , 2020, Cell Stem Cell.

[22]  E. Bonifacio,et al.  Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report , 2020, Nature Metabolism.

[23]  Shamus P. Keeler,et al.  SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function , 2020, Nature Immunology.

[24]  L. Marchand,et al.  Type 1 diabetes onset triggered by COVID-19 , 2020, Acta Diabetologica.

[25]  J. Ayres,et al.  A metabolic handbook for the COVID-19 pandemic , 2020, Nature metabolism.

[26]  N. Goldman,et al.  High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care , 2020, Diabetes Research and Clinical Practice.

[27]  Duc-Huy T. Nguyen,et al.  A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids , 2020, Cell Stem Cell.

[28]  Nudrat Noor,et al.  Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S. , 2020, Diabetes Care.

[29]  G. Guyatt,et al.  Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis , 2020, Canadian Medical Association Journal.

[30]  Victor G. Puelles,et al.  Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[31]  E. Ruppin,et al.  Predicting tissue-specific gene expression from whole blood transcriptome , 2020, Science Advances.

[32]  Q. Hu,et al.  Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer , 2020, Nature Communications.

[33]  Ying Jie Chee,et al.  Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus , 2020, Diabetes Research and Clinical Practice.

[34]  N. Vaninov.  In the eye of the COVID-19 cytokine storm , 2020, Nature Reviews Immunology.

[35]  Jian Chen,et al.  COVID‐19 infection may cause ketosis and ketoacidosis , 2020, Diabetes, obesity & metabolism.

[36]  Centers for Disease Control and Prevention CDC COVID-19 Response Team.  Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[37]  B. Jiang,et al.  Comorbidities and multi-organ injuries in the treatment of COVID-19 , 2020, The Lancet.

[38]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[39]  S. Anderson,et al.  Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and III Interferons. , 2019, Immunity.

[40]  Cheng Shi,et al.  Insulin-like peptides and the mTOR-TFEB pathway protect Caenorhabditis elegans hermaphrodites from mating-induced death , 2019, eLife.

[41]  R. Rabin,et al.  IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response , 2019, Front. Immunol..

[42]  Jun Sese,et al.  ChIP‐Atlas: a data‐mining suite powered by full integration of public ChIP‐seq data , 2018, EMBO reports.

[43]  N. Yuldasheva,et al.  Endothelial Insulin Receptor Restoration Rescues Vascular Function in Male Insulin Receptor Haploinsufficient Mice , 2018, Endocrinology.

[44]  Rahul C. Deo,et al.  Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease , 2017, Stem cell reports.

[45]  David S. Wishart,et al.  Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..

[46]  C. Kahn,et al.  Lipodystrophy Due to Adipose Tissue–Specific Insulin Receptor Knockout Results in Progressive NAFLD , 2016, Diabetes.

[47]  J. Celedón,et al.  Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma. , 2015, The Journal of allergy and clinical immunology.

[48]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[49]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[50]  I. Ben-Sahra,et al.  Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death , 2012, Cell Death and Differentiation.

[51]  M. Holzenberger,et al.  Knockout of Insulin-Like Growth Factor-1 Receptor Impairs Distal Lung Morphogenesis , 2012, PloS one.

[52]  A. Dopazo,et al.  Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass , 2011, BMC Medical Genomics.

[53]  Christopher T. Jones,et al.  A diverse array of gene products are effectors of the type I interferon antiviral response , 2011, Nature.

[54]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[55]  T. Ørntoft,et al.  STAT1 Is a Master Regulator of Pancreatic β-Cell Apoptosis and Islet Inflammation* , 2010, The Journal of Biological Chemistry.

[56]  J. Krishnan,et al.  Systematic review of the association between lung function and Type 2 diabetes mellitus , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[57]  N. Gretz,et al.  Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes , 2010, BMC Genomics.

[58]  Roland Lang,et al.  Mycobacteria‐induced granuloma necrosis depends on IRF‐1 , 2009, Journal of cellular and molecular medicine.

[59]  A. Avogaro,et al.  The metabolic syndrome, diabetes and lung dysfunction. , 2008, Diabetes & metabolism.

[60]  C. Liew,et al.  The peripheral-blood transcriptome: new insights into disease and risk assessment. , 2007, Trends in molecular medicine.

[61]  D. Tao,et al.  Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-α via MAPK and PI3K/Akt signaling pathways , 2007 .

[62]  Z. Modrušan,et al.  Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. , 2007, Differentiation; research in biological diversity.

[63]  K. Izuishi,et al.  The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[64]  Jiwang Chen,et al.  Expression profile of IGF system during lung injury and recovery in rats exposed to hyperoxia: A possible role of IGF‐1 in alveolar epithelial cell proliferation and differentiation , 2006, Journal of cellular biochemistry.

[65]  D. B. Allison,et al.  Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes , 2005, Diabetologia.

[66]  Lincoln Stein,et al.  Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Res..

[67]  F. Crea,et al.  Insulin-Like Growth Factor-1 as a Vascular Protective Factor , 2004, Circulation.

[68]  C. Kahn,et al.  Insulin receptor knockout mice. , 2003, Annual review of physiology.

[69]  M. Goldman.  Lung dysfunction in diabetes. , 2003, Diabetes care.

[70]  Y. Li,et al.  Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. , 2001, Journal of autoimmunity.

[71]  B. Calabretta,et al.  Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis , 1999, Molecular and Cellular Biology.

[72]  C. Mathieu,et al.  The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells. , 1999, European cytokine network.

[73]  T. Akaike,et al.  IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. , 1999, Biochemical and biophysical research communications.

[74]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[75]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[76]  C. Kahn,et al.  Insulin action and the insulin signaling network. , 1995, Endocrine reviews.

[77]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[78]  C. Kahn.  Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. , 1978, Metabolism: clinical and experimental.

[79]  W. Lim,et al.  Dexamethasone in Hospitalized Patients with Covid-19 , 2021 .

[80]  C. Kahn,et al.  Insulin receptor signaling in normal and insulin-resistant states. , 2014, Cold Spring Harbor perspectives in biology.

[81]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[82]  T. Taniguchi,et al.  IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.

[83]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[84]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.

[85]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .